Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Matrifen [fentanyl] for therapy of severe, chronic pain

Trial Profile

Matrifen [fentanyl] for therapy of severe, chronic pain

Phase of Trial: Phase IV

Latest Information Update: 11 Aug 2013

At a glance

  • Drugs Fentanyl (Primary)
  • Indications Pain
  • Focus Therapeutic Use
  • Acronyms MATRIX II
  • Sponsors Takeda Pharmaceuticals International GmbH
  • Most Recent Events

    • 07 Jan 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 07 Jan 2009 Actual end date (May 2008) added as reported by ClinicalTrials.gov.
    • 20 Nov 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top